Location: Paris, France
CIK: 0001121404 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Jul 28, 2026
Total Value: $534M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ODTX | Odyssey Therapeutics Inc. | 1,991,918 | $37.27M | 7.0% | $18.71 | — | COMMON STOCK | 67613T104 |
| TRAX | First Tracks Biotherapeutics Inc. | 821,917 | $16.54M | 3.1% | $20.12 | — | ORD SHS | 337185102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELDN | Eledon | 814,980 | $2.51M | 0.5% | $3.94 | — | — | 28617K101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MGTX | MeiraGTx Holdings plc | 12,197,737 | $165M | 30.9% | $5.86 | — | COM | G59665102 |
| INBX | Inhibrx Biosciences, Inc. | 1,157,926 | $110M | 20.5% | $15.23 | — | COM | 45720N103 |
| ANAB | AnaptysBio | 821,917 | $55.48M | 10.4% | $24.22 | — | COM | 032724106 |
| MPLT | MapLight Therapeutics Inc. | 912,041 | $32.69M | 6.1% | $16.75 | — | COM | 56565P103 |
| NVAX | Novavax | 6,880,481 | $64.81M | 12.1% | $9.64 | — | COM NEW | 670002401 |
| AGMB | Agomab Therapeutics NV | 2,783,096 | $36.12M | 6.8% | $10.49 | — | SPONSORED ADS | 00860C102 |
| QTTB | Q32 Bio Inc. | 244,083 | $3.11M | 0.6% | $31.58 | — | COM | 746964105 |
| IMRX | Immuneering Corp | 2,708,559 | $13.52M | 2.5% | $5.19 | — | CLASS A COM | 45254E107 |